Vanguard Global Advisers
BDSX icon

Vanguard Global Advisers’s Biodesix BDSX Stock Holding History

Vanguard Global Advisers’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8K Hold
1,054
– – ﹤0.01% 3276
2026
Q1 		$15.3K Buy
+1,054
New +$13.1K ﹤0.01% 3393

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Vanguard Global Advisers's BDSX Position: Q2 2026 in Review

Vanguard Global Advisers held its Biodesix (BDSX) position steady in Q2 2026 at 1,054 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3276.

Vanguard Global Advisers first reported a position in BDSX in Q1 2026 and has held it in 2 quarters since. 39 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Vanguard Global Advisers held 1,054 shares of Biodesix worth $23.8K as of Q2 2026.
  • Vanguard Global Advisers left its Biodesix share count unchanged in Q2 2026.
  • Biodesix made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3276 holding.
  • Vanguard Global Advisers first reported a position in Biodesix in Q1 2026 and has held it in 2 quarters since.
  • 39 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.